Latest filing published 11 Feb 2015 for CardioGenics Holdings Inc., €23k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +26.7%Entry 0.02 · Close at T+365 0.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James Essex: trading record in brief
James Essex is a declared insider of CardioGenics Holdings Inc., with filings sourced from SEC (Form 4). Activity is concentrated on a single trading day, 5 February 2015, with 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €45k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 11 February 2015, the filings show an open-market purchase worth €23k in CardioGenics Holdings Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James Essex
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 234,302 shares@ US$0.11Common StockSEC:0001493152-15-000447:0Canonical exit: 6 May 2015 (T+90)
- 227,273 shares@ US$0.11Common StockSEC:0001493152-15-000447:1Canonical exit: 6 May 2015 (T+90)
2 of 2 declarations